Heart failure
Scottish Health Purchasing Information Centre
Record ID 31998009126
English
Authors' objectives:
This report aims to answer the following questions:
1. Are ACE inhibitors now the treatment of choice in heart failure?
2. Should general practitioners have open access to echocardiography?
Authors' recommendations:
1. The ACE inhibitors are beneficial and cost-effective in most but not all causes of heart failure.
2. The cost of ACE inhibitors is falling. Their use in heart failure will be cost-saving if the resources saved in hospital are released for use in primary care.
3. Echocardiography is a valuable investigation and we recommend that general practitioners should have access to it.
Ideally, this should be by a rapid cardiology consultation including echocardiography as part of a total assessment of heart failure. If this cannot be provided, an open access service providing an echocardiography interpretation is the second option, and can provide a useful triage system to reduce the workload of the cardiology service.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.nhsconfed.net/shpic/doc19.htm
Year Published:
1998
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland, United Kingdom
MeSH Terms
- Angiotensin-Converting Enzyme Inhibitors
- Costs and Cost Analysis
- Echocardiography
- Heart Diseases
Contact
Organisation Name:
Scottish Health Purchasing Information Centre
Copyright:
Scottish Health Purchasing Information Centre
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.